Patent · US Active

Pharmaceutical formulation

US8524673B2 · kind B2 · utility

4Cited by
16References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 21, 2010
Grant dateSep 3, 2013
Priority date
Expiry dateOct 21, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical formulation for a PKC modulatory peptide and a transport moiety comprising the aforementioned components and an anti-aggregant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.